trial · primary record
Belzutifan
Carcinoma, Renal Cell
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 758 |
| Primary completion | 2030-11-27 |
| Primary endpoint | Progression-free Survival (PFS) |
| Registry ID | NCT07489495 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:53.350Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07489495
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- BELZUTIFAN · approval
- Belzutifan · compound